l really do not see the upside for Arrow, as they have already been marketing Sigma products and have a far superior sales team. In time Arrow would dwarf Sigma as its sales are increasing exponentially higher.
l also note around 5 mil in performance options which rather dwarfs the 2 - 3 mil in synergism savings. Seeems that directors will take quick profits and move along. Certainly see AWP with lower growth in the future. Cannot justify PE of 39 ! Looks like PE of 24 coming up
- Forums
- ASX - By Stock
- merger
AWP
arrow pharmaceuticals limited
l really do not see the upside for Arrow, as they have already...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
VMM
VIRIDIS MINING AND MINERALS LIMITED
Rafael Moreno, CEO
Rafael Moreno
CEO
SPONSORED BY The Market Online